Surgical sealants market are used to prevent leakage by binding tissue together internally and externally post-surgery or injury. The sealant products are made from natural or synthetic materials such as gelatin, fibrin, albumin, and polyethylene glycol (PEG) polymers. Surgical sealants and adhesives have significantly used over conventional approaches used for wound closure such as staples and sutures. This is mainly due to its several advantages such as safety, easy usability, and efficacy in several conditions in different tissues. The sealants typically form a chemical bond or barrier to stop the blood from oozing post-surgery. It further promotes wound healing and significantly removes the requirement of sutures. Surgical sealants are increasingly being used in the healthcare sector for various surgeries and injuries compared to conventional methods of wound closing.

Rising geriatric population and wide adoption of surgical sealants in surgical procedures joint replacement surgeries are some of the major factor driving the growth of the global surgical sealants market. The high cost of surgical sealants and adhesives in the low- and middle-income economies is the major factor hindering the growth of the market. The side effects associated with the sealants and adhesives, low surgical incision closure strength, stringent regulatory policies, and availability of cheaper alternative products such as sutures and staples are some of the factors limiting the growth of the global surgical sealants market. However, the rising prevalence of chronic diseases such as cancer and heart diseases, a significant increase in the number of FDA approvals, and increasing investments by major players in emerging economies is likely to fuel the market growth in the near future.

Browse full report at: Global Surgical Sealants Market

The surgical sealants market can be segmented on the basis of product type, indication, application, and end user. Based on the type of product, the market can be diversified into natural or biological surgical sealants and synthetic & semi-synthetic surgical sealants. The natural or biological surgical sealants segment is further divided into type and origin. Based on the type, the natural or biological surgical sealants market is segmented into polypeptide-based surgical sealants and polysaccharide-based surgical sealants. Based on origin, the natural or biological surgical sealants market is segmented into human blood-based and animal-based. The synthetic & semi-synthetic surgical sealants market is further segmented into cyanoacrylates, polyethylene glycol hydrogels, polyurethane-based tissue, and others (polyester-based tissue). Based on the indication, the surgical sealants market is segmented into surgical hemostasis, tissue sealing, and tissue engineering. Based on applications, the market is bifurcated into central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopaedic surgeries, cosmetic surgeries, urological surgeries, pulmonary surgeries, others (ophthalmic surgeries). Based on end users, the market is segmented into hospitals, clinics, and ambulatory surgical centers. Among the product type, the natural or biological surgical sealant segment acquire the largest market share in the surgical sealants market. This can be attributed to the wide adoption of fibrin-based polypeptide surgical sealants, as it is the only product that has received FDA approval for use in hemostats, adhesives, and sealants.

The global surgical sealants market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America holds a dominant position in the global surgical sealants market in 2017. The upsurge in geriatric population along with the wide availability of modern medical technology are some factors augmenting the growth of the surgical sealants market in the region. Moreover, the sedentary lifestyle of the population has significantly increased the surgical procedures in the region, which in turn fuels in the market growth in the region. Asia Pacific is projected to exhibit the fastest growth in the global surgical sealants market over the forecast period. This is mainly owing to a presence of huge pool of patients and increasing healthcare spending by government authorities and individuals. Moreover, the refining healthcare infrastructure due to increasing awareness of natural sealants among the population is one of the factors driving the growth of the surgical sealants market in the Asia Pacific.

Some of the key vendors of the surgical sealants market are Baxter, B. Braun Melsungen AG, C. R. Bard, Inc., Cardinal Health, Cohera Medical, Inc., Cryolife, Inc., Ethicon US, LLC, Integra Lifesciences, Mallinckrodt, and Vivostat A/S, among others. In order to sustain in the competitive market, these players adopt various strategies such as acquisitions, mergers, expansions, joint ventures and product development and so on. For instance, in September 2017, Cohera Medical Inc. signed an agreement with Terumo Corporation, a Japan-based medical device manufacturer. Under the terms of an agreement, the Cohera Medical Inc. will market its Cohera’s Sylys surgical sealants in Japan.

For related reports please visit​: Healthcare Industry Research